Your browser is no longer supported. Please, upgrade your browser.
HomeNewsScreenerMapsGroupsPortfolioInsiderFuturesForexCryptoBacktestsElite Help
publish chart | save to portfolio | create alert Type: candle | line | advanced | interactive | perf    Timeframe: intraday | daily | weekly | monthly  Settings
JNJ Johnson & Johnson daily Stock Chart
JNJ [NYSE]
Johnson & Johnson
Healthcare | Drug Manufacturers - Major | USA
statements
IndexDJIA S&P500 P/E26.96 EPS (ttm)5.25 Insider Own0.07% Shs Outstand2.64B Perf Week0.71%
Market Cap372.56B Forward P/E15.55 EPS next Y9.09 Insider Trans0.00% Shs Float2.63B Perf Month7.70%
Income14.15B PEG4.52 EPS next Q1.87 Inst Own70.00% Short Float0.63% Perf Quarter9.14%
Sales81.71B P/S4.56 EPS this Y7.60% Inst Trans-0.07% Short Ratio2.28 Perf Half Y1.39%
Book/sh22.09 P/B6.40 EPS next Y4.86% ROA9.20% Target Price150.78 Perf Year-4.37%
Cash/sh6.81 P/C20.76 EPS next 5Y5.96% ROE23.80% 52W Range121.00 - 148.59 Perf YTD9.55%
Dividend3.80 P/FCF37.72 EPS past 5Y3.10% ROI17.00% 52W High-4.85% Beta0.70
Dividend %2.69% Quick Ratio1.00 Sales past 5Y2.70% Gross Margin66.60% 52W Low16.84% ATR1.67
Employees135100 Current Ratio1.30 Sales Q/Q1.90% Oper. Margin19.90% RSI (14)68.62 Volatility0.86% 1.26%
OptionableYes Debt/Eq0.49 EPS Q/Q-54.50% Profit Margin17.30% Rel Volume0.57 Prev Close141.34
ShortableYes LT Debt/Eq0.46 EarningsJan 14 BMO Payout69.50% Avg Volume7.23M Price141.38
Recom2.10 SMA202.74% SMA505.79% SMA2004.72% Volume4,117,560 Change0.03%
Nov-20-19Initiated Cantor Fitzgerald Overweight $160
Oct-16-19Upgrade Atlantic Equities Underweight → Neutral
Oct-11-19Upgrade Bernstein Mkt Perform → Outperform $155
Jul-12-19Resumed Credit Suisse Outperform $156
May-28-19Initiated Goldman Buy
Jan-23-19Reiterated Barclays Equal Weight $137 → $135
Jul-12-18Upgrade Goldman Sell → Neutral
Jun-27-18Initiated Bernstein Mkt Perform $129
Apr-23-18Reiterated Citigroup Neutral $146 → $134
Apr-18-18Reiterated Stifel Hold $145 → $135
Jan-24-18Reiterated Stifel Hold $142 → $145
Jan-12-18Reiterated Wells Fargo Outperform $155 → $160
Jan-02-18Downgrade JP Morgan Overweight → Neutral
Oct-18-17Reiterated Stifel Hold $140 → $142
Oct-18-17Reiterated RBC Capital Mkts Outperform $144 → $147
Oct-18-17Reiterated Leerink Partners Outperform $150 → $165
Oct-16-17Reiterated Jefferies Buy $157 → $160
Oct-11-17Upgrade Jefferies Hold → Buy
Oct-09-17Upgrade Wells Fargo Market Perform → Outperform
Sep-25-17Initiated Citigroup Neutral $140
Dec-14-19 04:47PM  Biotech stocks are producing outsized gains heres how to get your share MarketWatch
Dec-13-19 02:42PM  FDA approves Sarepta's muscular dystrophy drug Yahoo Finance Video
10:46AM  Investor Interest Rising in QUAL ETF as Fund Sees Higher Inflows ETF Trends
Dec-12-19 10:23AM  ISRG Stock: Should You Invest In This Robotic Surgery Giant? Investor's Business Daily
07:34AM  Investors shift attention to next generation of CAR-T, new sickle cell treatments at major hematology meeting MarketWatch
Dec-10-19 05:45PM  Johnson & Johnson (JNJ) Dips More Than Broader Markets: What You Should Know Zacks
10:08AM  Johnson & Johnson to Host Investor Conference Call on Fourth-Quarter Results PR Newswire
Dec-09-19 07:40PM  UPDATE 1-J&J CEO spurns U.S. congressional hearing on carcinogens in talc products Reuters
04:35PM  J&J CEO Gorsky spurns U.S. congressional hearing on carcinogens in talc products Reuters
04:33PM  J&J CEO spurns U.S. congressional hearing on carcinogens in talc products Reuters
11:56AM  Johnson & Johnson Emerging Out Of A Dark Place Benzinga
09:42AM  J&J Presents Data on CAR-T Therapy Drug and Imbruvica at ASH Zacks
09:16AM  Bluebird Bio Stock Is Rising on Promising Cancer-Drug Data Barrons.com
09:02AM  Amgen Gets FDA Approval for J&J/Merck's Remicade Biosimilar Zacks
Dec-08-19 08:00AM  Johnson & Johnson Announces Commitment to Support Republic of Rwanda's Preparedness Against Ebola Outbreak PR Newswire
Dec-06-19 06:10PM  4 Health Care Stocks Gurus Broadly Own GuruFocus.com
03:38PM  Here's why Oregon rejected Johnson & Johnson's pelvic mesh settlement offer American City Business Journals
09:27AM  Pharma Stock Roundup: FDA Updates for RHHBY, AZN, MRK, No Asbestos in Talc Says JNJ Zacks
08:32AM  Glaxo Files NDA for Fostemsavir for Heavily Pre-Treated HIV Zacks
Dec-05-19 04:34PM  /C O R R E C T I O N -- Johnson & Johnson/ PR Newswire
04:29PM  Dow Jones Today: Trade Influenced Stocks More Than Impeachment News InvestorPlace
10:09AM  3M, Cisco share losses lead Dow's 75-point fall MarketWatch
09:07AM  J&J Stock Witnesses Volatility in '19: What to Expect in 2020 Zacks
09:00AM  Abbott Is One Of The Biggest Medical Stocks Should You Buy ABT Stock Now? Investor's Business Daily
07:44AM  UPDATE 2-Half a million Ebola vaccine doses to be stockpiled for emergency use Reuters
Dec-04-19 05:45PM  Johnson & Johnson (JNJ) Outpaces Stock Market Gains: What You Should Know Zacks
04:37PM  Wall Street rebounds on trade hopes Reuters Videos
04:36PM  Dow Jones Today: A Trade Redemption Story InvestorPlace
04:17PM  US STOCKS-Wall Street bounces back on renewed trade optimism Reuters
04:13PM  JNJ Stock Rallies As New Testing Rules Out Asbestos In Baby Powder Investor's Business Daily
04:00PM  Stock Market Gets Shot Of Adrenaline From Trump Trade Remarks; Dow's Apple, Goldman Rally Investor's Business Daily
02:39PM  US STOCKS-Wall Street rebounds on renewed U.S.-China trade optimism Reuters
02:13PM  Johnson & Johnson Says the Government Was Wrong About Asbestos In Baby Powder and Its Stock Is Rising Barrons.com
01:23PM  Stocks Bounce Broadly; J&J Breaks Out, But Is The Chart In Trouble? Investor's Business Daily
01:03PM  US STOCKS-Renewed hopes of trade deal push Wall Street higher Reuters
12:13PM  Dow Jones Jumps 200 Points As China News Fuels Stock Market Rally Investor's Business Daily
11:53AM  US STOCKS-Wall Street bounces on trade deal hopes Reuters
11:20AM  New Tests Find No Asbestos In J&J Baby Powder Is JNJ Stock A Safe Buy? Investor's Business Daily
10:31AM  US STOCKS-Wall St rises on renewed hopes of trade deal Reuters
10:10AM  AstraZeneca Sells Schizophrenia Drug Rights in US and Canada Zacks
09:45AM  Dow's nearly 175-point jump highlighted by gains in shares of Dow Inc., Johnson & Johnson MarketWatch
09:14AM  US STOCKS-Wall St set for higher open as report rekindles hopes of trade deal Reuters
07:59AM  J&J's (JNJ) New Tests Reveal No Asbestos in Baby Powders Zacks
06:42AM  Johnson & Johnson Says Government Is Wrong About Asbestos in Its Baby Powder TheStreet.com
Dec-03-19 07:00PM  UPDATE 1-J&J says new tests show no asbestos in Johnson's Baby Powder Reuters
06:42PM  J&J says new tests show no asbestos in Johnson's Baby Powder Reuters
06:39PM  Johnson & Johnson confirms no asbestos in Johnson's Baby Powder Reuters
05:39PM  Company Investigation Confirms No Asbestos in Johnson's Baby Powder PR Newswire
12:42PM  Investors question Lexington startup's dry eye treatment American City Business Journals
10:00AM  New Tests Find No Asbestos In J&J Baby Powder Is JNJ Stock A Safe Buy? Investor's Business Daily
Dec-02-19 06:27PM  Profit Takers Abound as Stocks Pull Back Investopedia
10:29AM  Ski-in, ski-out Vail chalet formerly owned by Johnson & Johnson heiress listed for $26M (Photos) American City Business Journals
08:49AM  Johnson & Johnson Stock Shaking Off Legal Headwinds Investopedia
Nov-30-19 10:59AM  Here are Wall Streets most-shorted stocks and how theyve performed, in one chart MarketWatch
Nov-29-19 11:45AM  The uniquely American opioid crisis, in 3 charts Yahoo Finance
09:24AM  Geron (GERN) Stock Surges 40% YTD: What's Driving the Rally? Zacks
08:48AM  China Negotiates Bargain Prices With Big Pharma Barrons.com
08:13AM  Attention Biotech Investors: Mark Your Calendar For These December PDUFA Dates Benzinga
Nov-28-19 09:37AM  Hedge Funds Are Standing By Johnson & Johnson (JNJ) Insider Monkey
07:00AM  The 3 Worst-Performing Health Care Stocks of 2019 So Far Barrons.com
Nov-27-19 02:06PM  Sarantis Keeps Growing Year After Year GuruFocus.com
12:36PM  Possible criminal probe undermines recovery in opioid stocks since global legal settlement announced MarketWatch
10:56AM  Federal probe launches against opioid makers: WSJ Yahoo Finance Video
09:37AM  Opioid Stocks Fall on News of Federal Criminal Investigation Barrons.com
09:35AM  Health Care ETFs Are Breaking Out, But Political Risks Linger In 2020 Benzinga
08:10AM  Should iShares Russell Top 200 Value ETF (IWX) Be on Your Investing Radar? Zacks
07:34AM  Fed Reportedly Opens Criminal Investigation on Opioid Makers Zacks
06:14AM  Pharma Companies Shares Tank As Feds Investigate Opioid Crisis Benzinga
Nov-26-19 05:54PM  BeiGene Shares Climb Nearly 50% After Amgen Deal GuruFocus.com
05:15PM  4 Stocks Warren Buffett and David Rolfe Agree On GuruFocus.com
04:15PM  Opioid Epidemic: Feds Reportedly Launch Criminal Probe Into Drugmakers Investor's Business Daily
Nov-25-19 03:53PM  Inefficient Market Theory: The Tylenol Poisoning Case GuruFocus.com
03:09PM  Shares of generic drugmakers rise on hope that legal issues are nearing an end MarketWatch
Nov-23-19 08:08PM  Here is the Most Popular Stock Among Hedge Funds Insider Monkey
03:41PM  Pfizer Is the Dows Worst Stock. A New Strategy Makes It Worth Another Look. Barrons.com
08:00AM  Why mental health coverage is still a struggle for employer-sponsored plans Yahoo Finance
01:54AM  [video]Top 5 Stock Market Movers in the Dow Jones This Week TheStreet.com
Nov-22-19 04:31PM  Dow Jones Today: Trade Progress Pushes Stocks, Healthcare Helps Dow InvestorPlace
12:07PM  [video]Top 5 Stock Winners in the Dow Jones Industrial Average This Week TheStreet.com
09:41AM  NewsBreak: Trump Looks to Let Florida, Others Import Prescription Drugs Investing.com
Nov-21-19 02:44PM  12 Dividend Stocks to Build a Monthly Income Calendar Kiplinger
11:00AM  Top Health Care Stocks for December 2019 Investopedia
12:02AM  Johnson & Johnson loses pelvic mesh class action in Australia Reuters
12:00AM  US jury payouts leave insurers facing $200bn hole Financial Times
Nov-20-19 11:00PM  Survey case studies: Gender on the agenda Financial Times
10:56PM  Johnson & Johnson loses pelvic mesh class action in Australia Reuters
04:32PM  Dow Jones Today: Investors Desperate for a Trade Deal InvestorPlace
09:22AM  Myovant Up on Successful Completion of Prostate Cancer Study Zacks
09:01AM  No More Tears for Johnson & Johnson? TheStreet.com
08:42AM  Buy Johnson & Johnson Stock, Analyst Says. The Pharma Giant Could Get Even Bigger. Barrons.com
05:06AM  [video]Johnson & Johnson Gets a Positive Nod From Cantor Fitzgerald TheStreet.com
Nov-19-19 09:41AM  The Zacks Analyst Blog Highlights: Alphabet, Amazon, Johnson & Johnson, Boeing and PetroChina Zacks
Nov-18-19 03:09PM  Top Analyst Reports for Alphabet, Amazon & Johnson & Johnson Zacks
12:38PM  Stock Market Live Updates: S&P 500, Nasdaq, Dow post record closing highs Yahoo Finance
11:43AM  Johnson & Johnson CEO Alex Gorsky on Leading Through the Next Decade Meredith Videos
11:17AM  Should You Be Pleased About The CEO Pay At Johnson & Johnson's (NYSE:JNJ) Simply Wall St.
10:53AM  J&J retests baby powder days after asbestos finding Yahoo Finance Video
07:19AM  How to Generate Retirement Income With a Total Return Strategy Barrons.com
Nov-17-19 03:40PM  AbbVie's Humira on Pace to Become Biggest Seller by 2024 GuruFocus.com
07:07AM  Hedge Funds Open Kimono: 5 Best Healthcare Stocks To Buy Insider Monkey
Johnson & Johnson, together with its subsidiaries, researches and develops, manufactures, and sells various products in the health care field worldwide. It operates in three segments: Consumer, Pharmaceutical, and Medical Devices. The Consumer segment offers baby care products under the JOHNSON'S brand; oral care products under the LISTERINE brand; beauty products under the AVEENO, CLEAN & CLEAR, DABAO, JOHNSON'S Adult, LE PETITE MARSEILLAIS, NEUTROGENA, and OGX brands; over-the-counter medicines, including acetaminophen products under the TYLENOL brand; cold, flu, and allergy products under the SUDAFED brand; allergy products under the BENADRYL and ZYRTEC brands; ibuprofen products under the MOTRIN IB brand; and acid reflux products under the PEPCID brand. This segment also provides women's health products, such as sanitary pads and tampons under the STAYFREE, CAREFREE, and o.b. brands; wound care products comprising adhesive bandages under the BAND-AID brand; and first aid products under the NEOSPORIN brand. The Pharmaceutical segment offers products in various therapeutic areas, including immunology, infectious diseases, neuroscience, oncology, pulmonary hypertension, and cardiovascular and metabolic diseases. The Medical Devices segment provides orthopedic products; general surgery, biosurgical, endomechanical, and energy products; electrophysiology products to treat cardiovascular diseases; sterilization and disinfection products to reduce surgical infection; diabetes care products; and vision care products, such as disposable contact lenses and ophthalmic products related to cataract and laser refractive surgery. The company markets its products to general public, and retail outlets and distributors, as well as distributes directly to wholesalers, hospitals, and health care professionals for prescription use. It has research and collaboration alliance with Morphic Therapeutic. The company was incorporated in 1887 and is based in New Brunswick, New Jersey.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
HEWSON MARILLYN ADirectorJun 11Buy139.683,000419,0403,000Jun 11 05:01 PM
Stoffels PaulusVice Chair, Exec CommitteeFeb 11Option Exercise0.0031,4280242,246Feb 12 09:15 PM
Taubert Jennifer LEVP, WW Chair, PharmaceuticalsFeb 11Option Exercise0.009,748078,388Feb 12 09:15 PM
Ullmann Michael HExec VP, General CounselFeb 11Option Exercise0.0013,2730139,434Feb 12 09:15 PM
Wengel Kathryn EEVP, Chief GSC OfficerFeb 11Option Exercise0.006,722044,546Feb 12 09:15 PM
Fasolo PeterExec VP, Chief HR OfficerFeb 11Option Exercise0.0012,609093,947Feb 12 09:15 PM
Wolk Joseph JExec VP, CFOFeb 11Option Exercise0.002,903014,405Feb 12 09:15 PM
Kapusta Ronald AController, CAOFeb 11Option Exercise0.002,839018,231Feb 12 09:15 PM
Duato JoaquinVice Chair, Exec CommitteeFeb 11Option Exercise0.0022,6240122,430Feb 12 09:14 PM
Gorsky AlexChairman, CEOFeb 11Option Exercise0.0073,9470414,703Feb 12 09:14 PM
McEvoy AshleyEVP, WW Chair, Medical DevicesFeb 11Option Exercise0.007,541021,809Feb 12 09:14 PM
Mesquita Jorge S.Exec VP, WW Chair, ConsumerFeb 11Option Exercise0.0016,968036,138Feb 12 09:14 PM
Sneed Michael EEVP, Global Corp Aff & COOFeb 11Option Exercise0.007,275051,687Feb 12 09:14 PM
Stoffels PaulusVice Chair, Exec CommitteeFeb 08Option Exercise0.0012,5710215,138Feb 12 09:15 PM
Taubert Jennifer LEVP, WW Chair, PharmaceuticalsFeb 08Option Exercise0.008,529072,205Feb 12 09:15 PM
Ullmann Michael HExec VP, General CounselFeb 08Option Exercise0.005,3090128,294Feb 12 09:15 PM
Wengel Kathryn EEVP, Chief GSC OfficerFeb 08Option Exercise0.005,882040,197Feb 12 09:15 PM
Fasolo PeterExec VP, Chief HR OfficerFeb 08Option Exercise0.005,044083,371Feb 12 09:15 PM
Wolk Joseph JExec VP, CFOFeb 08Option Exercise0.002,540012,239Feb 12 09:15 PM
Kapusta Ronald AController, CAOFeb 08Option Exercise0.002,484016,125Feb 12 09:15 PM
Duato JoaquinVice Chair, Exec CommitteeFeb 08Option Exercise0.009,0490102,604Feb 12 09:14 PM
Gorsky AlexChairman, CEOFeb 08Option Exercise0.0029,5790352,464Feb 12 09:14 PM
McEvoy AshleyEVP, WW Chair, Medical DevicesFeb 08Option Exercise0.006,599016,092Feb 12 09:14 PM
Mesquita Jorge S.Exec VP, WW Chair, ConsumerFeb 08Option Exercise0.006,787022,179Feb 12 09:14 PM
Sneed Michael EEVP, Global Corp Aff & COOFeb 08Option Exercise0.006,365046,239Feb 12 09:14 PM
open in yahoo | open in reuters | open in google